Meeting
2018 ASCO Annual Meeting
Characteristics and clinical outcomes of French patients diagnosed with advanced soft tissue sarcoma (aSTS) in real-life setting: Data from the European sarcoma biological and clinical data banking (ESBCB).
Authors
Jean-Yves Blay
Centre Léon Bérard, Lyon, France
Jean-Yves Blay , Axel Le Cesne , Florence Duffaud , Nicolas Penel , Simone Mathoulin-Pélissier , Francoise Ducimetiere , Yulia D'yachkova , Florence Chartier , Hisham Rassam , Pauline Cloitre
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Sarcoma
Track
Sarcoma
Sub Track
Soft Tissue Tumors
Citation
J Clin Oncol 36, 2018 (suppl; abstr 11548)
DOI
10.1200/JCO.2018.36.15_suppl.11548
Abstract #
11548
Poster Bd #
293
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Updated pooled analyses of first-line anti-PD1/PD-L1 inhibitors plus chemotherapy in advanced esophageal squamous cell carcinoma.
First Author: Maysa Vilbert
Poster
2022 ASCO Annual Meeting
Prognostic value of EZH2 expression for immunotherapy-based schemes in advanced soft-tissue sarcoma: A translational research from Spanish Group of Research on Sarcoma (GEIS).
First Author: David Silva Moura
Poster
2020 ASCO Virtual Scientific Program
Apatinib for patients (pts) with advanced soft tissue sarcoma (STS) after chemotherapy: A prospective, open-label, single-arm, multicentered study.
First Author: Haiyan Hu
Poster
2020 ASCO Virtual Scientific Program
Blood serum amyloid A as potential biomarker of pembrolizumab efficacy for patients affected by advanced non-small cell lung cancer (NSCLC) overexpressing PD-L1: Early results of the FoRECATT Study.
First Author: Vincenzo Di Noia